REQUEST A DEMO
Total
USD $0.00
Search more companies

Onesource Specialty Pharma Limited (India)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Onesource Specialty Pharma Limited Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

stelis biopharma is a biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based in Bangalore, Karnataka, India. The company offers process development and manufacturing infrastructure for drug substance and drug product. stelis biopharma claims to serve the global biopharmaceutical industry, providing customized services from process development to commercial manufacturing. The company has developed biologics for diabetes, osteoporosis, and haemorrhoids. stelis biopharma operates cGMP compliant facilities and has a team of professionals.

Legal Address
Star 1, Opp Iim Bangalorebilekahalli, Bannerghatta Road
Bangalore; Karnataka; Postal Code: 560076

Contact Details: Purchase the Onesource Specialty Pharma Limited report to view the information.

Website: http://www.stelis.com

Basic Information
Total Employees:
Purchase the Onesource Specialty Pharma Limited report to view the information.
Outstanding Shares:
Purchase the Onesource Specialty Pharma Limited report to view the information.
Registered Capital:
Purchase the Onesource Specialty Pharma Limited report to view the information.
Financial Auditors:
Purchase the Onesource Specialty Pharma Limited report to view the information.
Incorporation Date:
June 12, 2007
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
47.81%
Purchase this report to view the information.
26.38%
Purchase this report to view the information.
25.79%
Subsidiaries
Biolexis Private Limited
100%
Biolexis Pte. Ltd., Singapore
100%
Company Performance
Financial values in the chart are available after Onesource Specialty Pharma Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-68.91%
Total operating revenue
-66.34%
Operating profit (EBIT)
-96.82%
EBITDA
-111.96%
Net Profit (Loss) for the Period
-246.01%
Total assets
-17.75%
Total equity
-22.42%
Operating Profit Margin (ROS)
-933.17%
Net Profit Margin
-1772.34%
Return on Equity (ROE)
-79%
Debt to Equity Ratio
-7.48%
Quick Ratio
-0.18%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?